{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-028529","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.022168+00:00","generated_at":"2026-05-24T03:39:38.865719+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nasdaq panel grants Brainstorm Cell Therapeutics extension to June 30, 2025 to regain listing compliance","bullets":["Nasdaq Hearings Panel granted extension to June 30, 2025 to regain compliance with $35M minimum Market Value of Listed Securities.","Company plans to meet $2.5M minimum stockholders' equity requirement as alternative to MVLS compliance.","Extension conditioned on demonstrating compliance with Nasdaq Listing Rule 5550 and progress in capital raising.","Company cannot assure success in raising capital or satisfying equity requirement by the extension date.","Plan presented at February 25, 2025 hearing; capital raising activities are a key component."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-028529","json":"https://secwatch.observer/filing/0001104659-25-028529.json","markdown":"https://secwatch.observer/filing/0001104659-25-028529.md","text":"https://secwatch.observer/filing/0001104659-25-028529.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925028529/0001104659-25-028529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925028529/tm2510584d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:39:38.865719+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001193125-26-251517","ticker":"LESL","company_name":"Leslie's, Inc.","filed_at":"2026-06-01T20:28:42+00:00","headline":"Leslie's regains Nasdaq compliance for minimum market value of publicly held shares","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251517","json":"https://secwatch.observer/filing/0001193125-26-251517.json","markdown":"https://secwatch.observer/filing/0001193125-26-251517.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821806/000119312526251517/0001193125-26-251517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821806/000119312526251517/lesl-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068591","ticker":"VYGR","company_name":"Voyager Therapeutics, Inc.","filed_at":"2026-06-01T12:00:26+00:00","headline":"FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068591","json":"https://secwatch.observer/filing/0001104659-26-068591.json","markdown":"https://secwatch.observer/filing/0001104659-26-068591.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926068591/0001104659-26-068591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926068591/tm2616041d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001476840-26-000050","ticker":"EXFY","company_name":"Expensify, Inc.","filed_at":"2026-05-29T21:15:09+00:00","headline":"Expensify regains Nasdaq minimum bid price compliance","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001476840-26-000050","json":"https://secwatch.observer/filing/0001476840-26-000050.json","markdown":"https://secwatch.observer/filing/0001476840-26-000050.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1476840/000147684026000050/0001476840-26-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1476840/000147684026000050/exfy-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001178913-26-002988","ticker":"SLXN","company_name":"Silexion Therapeutics Corp","filed_at":"2026-05-29T11:00:25+00:00","headline":"Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted","event_type":"regulatory","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-002988","json":"https://secwatch.observer/filing/0001178913-26-002988.json","markdown":"https://secwatch.observer/filing/0001178913-26-002988.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/0001178913-26-002988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/zk2635442.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062172","ticker":"RR","company_name":"RICHTECH ROBOTICS INC.","filed_at":"2026-05-28T20:49:32+00:00","headline":"Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062172","json":"https://secwatch.observer/filing/0001213900-26-062172.json","markdown":"https://secwatch.observer/filing/0001213900-26-062172.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1963685/000121390026062172/0001213900-26-062172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1963685/000121390026062172/ea0292546-8k_richtech.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-243074","ticker":"MNKD","company_name":"MANNKIND CORP","filed_at":"2026-05-28T12:37:11+00:00","headline":"FDA releases MannKind from Afrezza malignancy study; sBLA for children PDUFA May 29","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-243074","json":"https://secwatch.observer/filing/0001193125-26-243074.json","markdown":"https://secwatch.observer/filing/0001193125-26-243074.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/899460/000119312526243074/0001193125-26-243074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899460/000119312526243074/mnkd-20260527.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-025419","ticker":"SNAL","company_name":"Snail, Inc.","filed_at":"2026-05-27T20:25:45+00:00","headline":"Snail receives Nasdaq extension to Sept 22, 2026 to regain listing compliance","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025419","json":"https://secwatch.observer/filing/0001493152-26-025419.json","markdown":"https://secwatch.observer/filing/0001493152-26-025419.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1886894/000149315226025419/0001493152-26-025419-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1886894/000149315226025419/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-240645","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-05-27T13:10:06+00:00","headline":"Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-240645","json":"https://secwatch.observer/filing/0001193125-26-240645.json","markdown":"https://secwatch.observer/filing/0001193125-26-240645.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/0001193125-26-240645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/d129501d8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}